NCBI Taxonomy: 1779167
Spirophorina (ncbi_taxid: 1779167)
found 58 associated metabolites at suborder taxonomy rank level.
Ancestor: Tetractinellida
Child Taxonomies: Azoricidae, Tetillidae, Stupendidae, Siphonidiidae, Scleritodermidae
Cholestenone
Cholestenone belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. Thus, cholestenone is considered to be a sterol lipid molecule. Cholestenone is a very hydrophobic molecule, practically insoluble in water, and relatively neutral. Cholestenone is a dehydrocholestanone. It is a product of cholesterol oxidase {EC 1.1.3.6] in the Bile acid biosynthesis pathway (KEGG). [HMDB] Cholestenone (4-Cholesten-3-one), the intermediate oxidation product of cholesterol, is metabolized primarily in the liver. Cholestenone is highly mobile in membranes and influences cholesterol flip-flop and efflux. Cholestenone may cause long-term functional defects in cells[1][2]. Cholestenone (4-Cholesten-3-one), the intermediate oxidation product of cholesterol, is metabolized primarily in the liver. Cholestenone is highly mobile in membranes and influences cholesterol flip-flop and efflux. Cholestenone may cause long-term functional defects in cells[1][2].
Cholesterol
Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues and transported in the blood plasma of all animals. The name originates from the Greek chole- (bile) and stereos (solid), and the chemical suffix -ol for an alcohol. This is because researchers first identified cholesterol in solid form in gallstones in 1784. In the body, cholesterol can exist in either the free form or as an ester with a single fatty acid (of 10-20 carbons in length) covalently attached to the hydroxyl group at position 3 of the cholesterol ring. Due to the mechanism of synthesis, plasma cholesterol esters tend to contain relatively high proportions of polyunsaturated fatty acids. Most of the cholesterol consumed as a dietary lipid exists as cholesterol esters. Cholesterol esters have a lower solubility in water than cholesterol and are more hydrophobic. They are hydrolyzed by the pancreatic enzyme cholesterol esterase to produce cholesterol and free fatty acids. Cholesterol has vital structural roles in membranes and in lipid metabolism in general. It is a biosynthetic precursor of bile acids, vitamin D, and steroid hormones (glucocorticoids, estrogens, progesterones, androgens and aldosterone). In addition, it contributes to the development and functioning of the central nervous system, and it has major functions in signal transduction and sperm development. Cholesterol is a ubiquitous component of all animal tissues where much of it is located in the membranes, although it is not evenly distributed. The highest proportion of unesterified cholesterol is in the plasma membrane (roughly 30-50\\\\% of the lipid in the membrane or 60-80\\\\% of the cholesterol in the cell), while mitochondria and the endoplasmic reticulum have very low cholesterol contents. Cholesterol is also enriched in early and recycling endosomes, but not in late endosomes. The brain contains more cholesterol than any other organ where it comprises roughly a quarter of the total free cholesterol in the human body. Of all the organic constituents of blood, only glucose is present in a higher molar concentration than cholesterol. Cholesterol esters appear to be the preferred form for transport in plasma and as a biologically inert storage (de-toxified) form. They do not contribute to membranes but are packed into intracellular lipid particles. Cholesterol molecules (i.e. cholesterol esters) are transported throughout the body via lipoprotein particles. The largest lipoproteins, which primarily transport fats from the intestinal mucosa to the liver, are called chylomicrons. They carry mostly triglyceride fats and cholesterol that are from food, especially internal cholesterol secreted by the liver into the bile. In the liver, chylomicron particles give up triglycerides and some cholesterol. They are then converted into low-density lipoprotein (LDL) particles, which carry triglycerides and cholesterol on to other body cells. In healthy individuals, the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. (Lack of information on LDL particle number and size is one of the major problems of conventional lipid tests.). In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. There is a worldwide trend to believe that lower total cholesterol levels tend to correlate with lower atherosclerosis event rates (though some studies refute this idea). As a result, cholesterol has become a very large focus for the scientific community trying to determine the proper amount of cholesterol needed in a healthy diet. However, the primary association of atherosclerosis with c... Constituent either free or as esters, of fish liver oils, lard, dairy fats, egg yolk and bran Cholesterol is the major sterol in mammals. It is making up 20-25\\% of structural component of the plasma membrane. Plasma membranes are highly permeable to water but relatively impermeable to ions and protons. Cholesterol plays an important role in determining the fluidity and permeability characteristics of the membrane as well as the function of both the transporters and signaling proteins[1][2]. Cholesterol is also an endogenous estrogen-related receptor α (ERRα) agonist[3]. Cholesterol is the major sterol in mammals. It is making up 20-25\% of structural component of the plasma membrane. Plasma membranes are highly permeable to water but relatively impermeable to ions and protons. Cholesterol plays an important role in determining the fluidity and permeability characteristics of the membrane as well as the function of both the transporters and signaling proteins[1][2]. Cholesterol is also an endogenous estrogen-related receptor α (ERRα) agonist[3].
Batyl alcohol
C26170 - Protective Agent > C797 - Radioprotective Agent 3-(Octadecyloxy)propane-1,2-diol is an endogenous metabolite.
Brassicasterol
Brassicasterol belongs to the class of organic compounds known as ergosterols and derivatives. These are steroids containing ergosta-5,7,22-trien-3beta-ol or a derivative thereof, which is based on the 3beta-hydroxylated ergostane skeleton. Thus, brassicasterol is considered to be a sterol lipid molecule. Brassicasterol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Brassicasterol is a potential CSF biomarker for Alzheimer’s disease (PMID: 21585343). C1907 - Drug, Natural Product > C28178 - Phytosterol > C68437 - Unsaturated Phytosterol Constituent of Brassica rapa oil Brassicasterol, a metabolite of Ergosterol, plays a role in the inhibitory effect on bladder carcinogenesis promotion via androgen signaling[1]. Brassicasterol shows dual anti-infective properties against HSV-1 (IC50=1.2 μM) and Mycobacterium tuberculosis, and cardiovascular protective effect[2]. Brassicasterol exerts an anti-cancer effect by dual-targeting AKT and androgen receptor signaling in prostate cancer[3]. Brassicasterol is a metabolite of Ergosterol and has cardiovascular protective effects. Brassicasterol exerts anticancer effects in prostate cancer through dual targeting of AKT and androgen receptor signaling pathways. Brassicasterol inhibits HSV-1 (IC50=1.2 μM) and Mycobacterium tuberculosis. Brassicasterol also inhibits sterol δ 24-reductase, slowing the progression of atherosclerosis. Brassicasterol is also a cerebrospinal fluid biomarker for Alzheimer's disease[1][2][3][4][5][6]. Brassicasterol, a metabolite of Ergosterol, plays a role in the inhibitory effect on bladder carcinogenesis promotion via androgen signaling[1]. Brassicasterol shows dual anti-infective properties against HSV-1 (IC50=1.2 μM) and Mycobacterium tuberculosis, and cardiovascular protective effect[2]. Brassicasterol exerts an anti-cancer effect by dual-targeting AKT and androgen receptor signaling in prostate cancer[3].
24-Methylenecholesterol
24-Methylenecholesterol, also known as chalinasterol or ostreasterol, belongs to the class of organic compounds known as ergosterols and derivatives. These are steroids containing ergosta-5,7,22-trien-3beta-ol or a derivative thereof, which is based on the 3beta-hydroxylated ergostane skeleton. Thus, 24-methylenecholesterol is considered to be a sterol lipid molecule. 24-Methylenecholesterol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. 24-Methylenecholesterol is involved in the biosynthesis of steroids. 24-Methylenecholesterol is converted from 5-dehydroepisterol by 7-dehydrocholesterol reductase (EC 1.3.1.21). 24-Methylenecholesterol is converted into campesterol by delta24-sterol reductase (EC 1.3.1.72). 24-methylenecholesterol is a 3beta-sterol having the structure of cholesterol with a methylene group at C-24. It has a role as a mouse metabolite. It is a 3beta-sterol and a 3beta-hydroxy-Delta(5)-steroid. It is functionally related to a cholesterol. 24-Methylenecholesterol is a natural product found in Echinometra lucunter, Ulva fasciata, and other organisms with data available. A 3beta-sterol having the structure of cholesterol with a methylene group at C-24. Constituent of clams and oysters 24-Methylenecholesterol (Ostreasterol), a natural marine sterol, stimulates cholesterol acyltransferase in human macrophages. 24-Methylenecholesterol possess anti-aging effects in yeast. 24-methylenecholesterol enhances honey bee longevity and improves nurse bee physiology[1][2][3].
Clionasterol
Clionasterol is a triterpenoid isolated from the Indian marine red alga Gracilaria edulis, the sponge Veronica aerophoba and the Kenyan Marine Green. Macroalga Halimeda macroloba. It is a potent inhibitor of complement component C1. (PMID 12624828). D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites
Cholesterol
A cholestanoid consisting of cholestane having a double bond at the 5,6-position as well as a 3beta-hydroxy group. Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong. Cholesterol is the major sterol in mammals. It is making up 20-25\\% of structural component of the plasma membrane. Plasma membranes are highly permeable to water but relatively impermeable to ions and protons. Cholesterol plays an important role in determining the fluidity and permeability characteristics of the membrane as well as the function of both the transporters and signaling proteins[1][2]. Cholesterol is also an endogenous estrogen-related receptor α (ERRα) agonist[3]. Cholesterol is the major sterol in mammals. It is making up 20-25\% of structural component of the plasma membrane. Plasma membranes are highly permeable to water but relatively impermeable to ions and protons. Cholesterol plays an important role in determining the fluidity and permeability characteristics of the membrane as well as the function of both the transporters and signaling proteins[1][2]. Cholesterol is also an endogenous estrogen-related receptor α (ERRα) agonist[3].
Brassicasterol
An 3beta-sterol that is (22E)-ergosta-5,22-diene substituted by a hydroxy group at position 3beta. It is a phytosterol found in marine algae, fish, and rapeseed oil. C1907 - Drug, Natural Product > C28178 - Phytosterol > C68437 - Unsaturated Phytosterol Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong. Brassicasterol, a metabolite of Ergosterol, plays a role in the inhibitory effect on bladder carcinogenesis promotion via androgen signaling[1]. Brassicasterol shows dual anti-infective properties against HSV-1 (IC50=1.2 μM) and Mycobacterium tuberculosis, and cardiovascular protective effect[2]. Brassicasterol exerts an anti-cancer effect by dual-targeting AKT and androgen receptor signaling in prostate cancer[3]. Brassicasterol is a metabolite of Ergosterol and has cardiovascular protective effects. Brassicasterol exerts anticancer effects in prostate cancer through dual targeting of AKT and androgen receptor signaling pathways. Brassicasterol inhibits HSV-1 (IC50=1.2 μM) and Mycobacterium tuberculosis. Brassicasterol also inhibits sterol δ 24-reductase, slowing the progression of atherosclerosis. Brassicasterol is also a cerebrospinal fluid biomarker for Alzheimer's disease[1][2][3][4][5][6]. Brassicasterol, a metabolite of Ergosterol, plays a role in the inhibitory effect on bladder carcinogenesis promotion via androgen signaling[1]. Brassicasterol shows dual anti-infective properties against HSV-1 (IC50=1.2 μM) and Mycobacterium tuberculosis, and cardiovascular protective effect[2]. Brassicasterol exerts an anti-cancer effect by dual-targeting AKT and androgen receptor signaling in prostate cancer[3].
Cholestenone
Cholestenone (4-Cholesten-3-one), the intermediate oxidation product of cholesterol, is metabolized primarily in the liver. Cholestenone is highly mobile in membranes and influences cholesterol flip-flop and efflux. Cholestenone may cause long-term functional defects in cells[1][2]. Cholestenone (4-Cholesten-3-one), the intermediate oxidation product of cholesterol, is metabolized primarily in the liver. Cholestenone is highly mobile in membranes and influences cholesterol flip-flop and efflux. Cholestenone may cause long-term functional defects in cells[1][2].
clionasterol
A member of the class of phytosterols that is poriferast-5-ene carrying a beta-hydroxy substituent at position 3. D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites
n-[1-({13-ethylidene-3,6,9,12,15,21,29,33,36-nonahydroxy-10-[1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-(1-hydroxyethyl)-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23(27),25,29,33,36-tridecaen-32-yl}-c-hydroxycarbonimidoyl)prop-1-en-1-yl]-2-hydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]trideca-4,6-dienimidic acid
6-hydroxy-5-[(2s,4r,5s)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methylpyran-2-one
(2s,3r,4e,6e)-n-[(1e)-1-{[(1s,4r,10r,13e,16s,27r,31s,32s,35r)-13-ethylidene-3,6,9,12,15,21,25,29,33,36-decahydroxy-10-[(1s)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-[(1r)-1-hydroxyethyl]-27-methoxy-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23,25,29,33,36-tridecaen-32-yl]-c-hydroxycarbonimidoyl}prop-1-en-1-yl]-2-hydroxy-3-{[(2r,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}tetradeca-4,6-dienimidic acid
6-hydroxy-3-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyran-2-one
{11-methoxy-9-[2-(3-methoxy-2-methylbut-1-en-1-yl)-1,3-oxazol-4-yl]-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl}oxyphosphonic acid
C30H48NO10P (613.3015677999999)
1-(5-ethyl-6-methylheptan-2-yl)-7-methoxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene
1-(5-ethyl-6-methylheptan-2-yl)-7-methoxy-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene
(1r,3ar,5as,7s,9as,11ar)-1-[(2r,5r)-5,6-dimethylheptan-2-yl]-7-methoxy-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene
(2r)-n-[(2s,6s,9s,15s,19z,21e)-6-[(2s)-butan-2-yl]-8-hydroxy-2-[(4-hydroxyphenyl)methyl]-19,21-dimethyl-4,5,14,18-tetraoxo-17-oxa-25-thia-3,7,13,26-tetraazatricyclo[21.2.1.0⁹,¹³]hexacosa-1(26),7,19,21,23-pentaen-15-yl]-1-[(2r)-3-methoxy-2-(sulfoamino)propanoyl]pyrrolidine-2-carboximidic acid
n-[1-({13-ethylidene-3,6,9,12,15,21,29,33,36-nonahydroxy-10-[1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-(1-hydroxyethyl)-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23(27),25,29,33,36-tridecaen-32-yl}-c-hydroxycarbonimidoyl)prop-1-en-1-yl]-2-hydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]tetradeca-4,6-dienimidic acid
(2s,3r,4e,6e)-n-[(1e)-1-{[(1s,4r,10r,13e,16s,31s,32s,35r)-13-ethylidene-3,6,9,12,15,21,29,33,36-nonahydroxy-10-[(1s)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-[(1r)-1-hydroxyethyl]-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23(27),25,29,33,36-tridecaen-32-yl]-c-hydroxycarbonimidoyl}prop-1-en-1-yl]-2-hydroxy-3-{[(2r,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}tetradeca-4,6-dienimidic acid
{13-hydroxy-11-methoxy-9-[2-(3-methoxy-2-methylbut-1-en-1-yl)-1,3-oxazol-4-yl]-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl}oxyphosphonic acid
C30H48NO11P (629.2964827999999)
3-{[(3ar,6s,7r,11r,18r)-7-[(1s,2s,4e,6e)-7-(4-ethoxyphenyl)-1,2-dihydroxyhepta-4,6-dien-1-yl]-2,5,6,9,11,14,17,20-octahydroxy-22-methyl-23-oxo-3h,3ah,6h,7h,10h,11h,12h,15h,18h,21h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-18-yl]methyl}-1h-indole-2-carboxylic acid
6-hydroxy-5-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methylpyran-2-one
(2s,3r,4e,6e)-n-[(1e)-1-{[(1s,4r,10r,13e,16s,31s,32s,35r)-13-ethylidene-3,6,9,12,15,21,29,33,36-nonahydroxy-10-[(1s)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-[(1r)-1-hydroxyethyl]-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23(27),25,29,33,36-tridecaen-32-yl]-c-hydroxycarbonimidoyl}prop-1-en-1-yl]-2-hydroxy-3-{[(2r,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}trideca-4,6-dienimidic acid
(1r,3as,3bs,9ar,9bs,11ar)-1-[(2r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
6-hydroxy-3-[(2s,4r,5s)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyran-2-one
3-{[(3as,6s,7r,11r,18r,24as)-7-[(1s,2s,3s,8e)-1,2-dihydroxy-9-(4-methoxyphenyl)-3-methylnon-8-en-1-yl]-2,5,6,9,11,14,17,20,24a-nonahydroxy-22-methyl-23-oxo-3h,3ah,6h,7h,10h,11h,12h,15h,18h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-18-yl]methyl}-1h-indole-2-carboxylic acid
(2s)-n-[(2s,6s,9s,15s,19z,21z)-6-[(2s)-butan-2-yl]-8-hydroxy-2-[(4-hydroxyphenyl)methyl]-19,21-dimethyl-4,5,14,18-tetraoxo-17-oxa-25-thia-3,7,13,26-tetraazatricyclo[21.2.1.0⁹,¹³]hexacosa-1(26),7,19,21,23-pentaen-15-yl]-1-[(2r)-3-methoxy-2-(sulfoamino)propanoyl]pyrrolidine-2-carboximidic acid
(3ar,6s,7r,11r,18r,24ar)-7-[(1s,2s,3s,4e,6e,8e)-1,2-dihydroxy-3-methyl-9-phenylnona-4,6,8-trien-1-yl]-2,5,6,9,11,14,17,20,24a-nonahydroxy-18-(1h-indol-3-ylmethyl)-22-methyl-3h,3ah,6h,7h,10h,11h,12h,15h,18h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-23-one
1-(5,6-dimethylheptan-2-yl)-7-methoxy-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene
n-[1-({13-ethylidene-3,6,9,12,15,21,25,29,33,36-decahydroxy-10-[1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-(1-hydroxyethyl)-27-methoxy-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23,25,29,33,36-tridecaen-32-yl}-c-hydroxycarbonimidoyl)prop-1-en-1-yl]-2-hydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]tetradeca-4,6-dienimidic acid
[(1r,3s,4s,6s,9s,11s,15r)-11-methoxy-9-{2-[(1e,3r)-3-methoxy-2-methylbut-1-en-1-yl]-1,3-oxazol-4-yl}-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl]oxyphosphonic acid
C30H48NO10P (613.3015677999999)
[(1r,3s,4s,6s,9s,11s,13r,15s)-13-hydroxy-11-methoxy-9-{2-[(1e,3r)-3-methoxy-2-methylbut-1-en-1-yl]-1,3-oxazol-4-yl}-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl]oxyphosphonic acid
C30H48NO11P (629.2964827999999)
(2s,5s,7s,11r,14r,15r)-14-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-5-methoxy-2,15-dimethyl-18-oxatetracyclo[8.7.1.0²,⁷.0¹¹,¹⁵]octadeca-1(17),9-diene
(3ar,6s,7r,11r,18r,24ar)-7-[(1s,2s,3s,4e,6e,8e)-1,2-dihydroxy-3,7-dimethyl-9-phenylnona-4,6,8-trien-1-yl]-2,5,6,9,11,14,17,20,24a-nonahydroxy-18-(1h-indol-3-ylmethyl)-22-methyl-3h,3ah,6h,7h,10h,11h,12h,15h,18h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-23-one
(2s,3r,4e,6e)-n-[(1e)-1-{[(1s,13e,31s,32s,35r)-13-ethylidene-3,6,9,12,15,21,29,33,36-nonahydroxy-10-[(1s)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-[(1r)-1-hydroxyethyl]-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23(27),25,29,33,36-tridecaen-32-yl]-c-hydroxycarbonimidoyl}prop-1-en-1-yl]-2-hydroxy-3-{[(3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentadeca-4,6-dienimidic acid
(3ar,6s,7r,11r,18z,24ar)-7-[(1s,2s,3s,4e,6e,8e)-1,2-dihydroxy-3-methyl-9-phenylnona-4,6,8-trien-1-yl]-2,5,6,9,11,14,17,20,24a-nonahydroxy-18-(1h-indol-3-ylmethylidene)-22-methyl-3h,3ah,6h,7h,10h,11h,12h,15h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-23-one
14-(5-ethyl-6-methylheptan-2-yl)-5-methoxy-2,15-dimethyl-18-oxatetracyclo[8.7.1.0²,⁷.0¹¹,¹⁵]octadeca-1(17),9-diene
n-[1-({13-ethylidene-3,6,9,12,15,21,29,33,36-nonahydroxy-10-[1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-(1-hydroxyethyl)-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23(27),25,29,33,36-tridecaen-32-yl}-c-hydroxycarbonimidoyl)prop-1-en-1-yl]-2-hydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentadeca-4,6-dienimidic acid
(2s,3r,4e,6e)-n-[(1e)-1-{[(1s,13e,31s,32s,35r)-13-ethylidene-3,6,9,12,15,21,29,33,36-nonahydroxy-10-[(1s)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-[(1r)-1-hydroxyethyl]-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23(27),25,29,33,36-tridecaen-32-yl]-c-hydroxycarbonimidoyl}prop-1-en-1-yl]-2-hydroxy-3-{[(3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}trideca-4,6-dienimidic acid
9a,11a-dimethyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol
(6r)-6-[(1r,3as,3br,9as,9bs,11ar)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methylheptan-1-ol
(1r,3as,3bs,5as,7s,9as,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-ol
(2s,3r,4e,6e)-n-[(1e)-1-{[(1s,4r,10r,13z,16s,27r,31s,32s,35r)-13-ethylidene-3,6,9,12,15,21,25,29,33,36-decahydroxy-10-[(1s)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-[(1r)-1-hydroxyethyl]-27-methoxy-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23,25,29,33,36-tridecaen-32-yl]-c-hydroxycarbonimidoyl}prop-1-en-1-yl]-2-hydroxy-3-{[(2r,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}tetradeca-4,6-dienimidic acid
(2s,3r,4e,6e)-n-[(1e)-1-{[(1s,13e,31s,32s,35r)-13-ethylidene-3,6,9,12,15,21,29,33,36-nonahydroxy-10-[(1s)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-[(1r)-1-hydroxyethyl]-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23(27),25,29,33,36-tridecaen-32-yl]-c-hydroxycarbonimidoyl}prop-1-en-1-yl]-2-hydroxy-3-{[(3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}tetradeca-4,6-dienimidic acid
(3ar,6s,7r,11r,18z,24ar)-7-[(1s,2s,3s,4e,6e,8e)-1,2-dihydroxy-3,7-dimethyl-9-phenylnona-4,6,8-trien-1-yl]-2,5,6,9,11,14,17,20,24a-nonahydroxy-18-(1h-indol-3-ylmethylidene)-22-methyl-3h,3ah,6h,7h,10h,11h,12h,15h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-23-one
(2s,3r,4e,6e)-n-[(1e)-1-{[(1s,4r,10r,13e,16s,31s,32s,35r)-13-ethylidene-3,6,9,12,15,21,29,33,36-nonahydroxy-10-[(1s)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-4-[2-(c-hydroxycarbonimidoyl)ethyl]-35-[(1r)-1-hydroxyethyl]-31-methyl-2,5,8,11,14,24,26,30,34,37-decaazatetracyclo[14.12.9.1¹⁸,²².0²³,²⁷]octatriaconta-2,5,8,11,14,18,20,22(38),23(27),25,29,33,36-tridecaen-32-yl]-c-hydroxycarbonimidoyl}prop-1-en-1-yl]-2-hydroxy-3-{[(2r,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentadeca-4,6-dienimidic acid
14-(5-ethyl-6-methylheptan-2-yl)-5-methoxy-2,15-dimethyl-18-oxatetracyclo[8.7.1.0²,⁷.0¹¹,¹⁵]octadeca-1(17),10-diene
(1r,3ar,5as,7s,9as,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-7-methoxy-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene
(2s,5s,7s,14r,15r)-14-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-5-methoxy-2,15-dimethyl-18-oxatetracyclo[8.7.1.0²,⁷.0¹¹,¹⁵]octadeca-1(17),10-diene
(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-7-methoxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene
3-{[(3r,3as,6s,7r,11r,18r,24as)-7-[(1s,2s,3r,8e)-1,2-dihydroxy-9-(4-methoxyphenyl)-3-methylnon-8-en-1-yl]-2,3,5,6,9,11,14,17,20,24a-decahydroxy-22-methyl-23-oxo-3h,3ah,6h,7h,10h,11h,12h,15h,18h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-18-yl]methyl}-1h-indole-2-carboxylic acid
C47H62N8O16 (994.4283571999999)